TrialEBioMedicine2024

The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells.

Michael I Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.